Home›Search›Frontiers in Clinical Drug Research - Anti Allergy Agents
Frontiers in Clinical Drug Research - Anti Allergy Agents
Bentham Science Publishers · Netherlands · Est. 2018
ISSN2214-6938
SJR Q4✓ Scopus / SJR
5
/ 100
High Risk
Score Breakdown
✓ Scopus Q4+5
Total5
Journal Impact Factor
Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals.
SJR Score
0.133
H-Index
3
Total Works
27
Total Citations
24
2yr Mean Citedness
0.00
Free JIF alternative
Aims & Scope✦ Inferred from recent articles
This journal focuses on research into anti-allergic agents, including the development of novel heterocyclic compounds, the role of cytokines like resistin in allergic reactions, and the therapeutic potential of medicinal plants and helminth therapy for allergic and immunologic disorders. It also examines the impact of microbiota and factors like aspirin on allergies and asthma.
AI-summarised from recent articles · verify on the publisher page
⚡ Speed vs Prestige
How does this journal balance review speed with impact level?
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Articles published
Times cited
2018
2020
2022
Source: OpenAlex · Note: citations accumulate over time so older years appear higher
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
Drug DiscoveryQ4
Immunology and AllergyQ4
PharmacologyQ4
Pharmacology (medical)Q4
Subject Classification
Scopus Categories
PharmacologyPharmacology (medical)Drug DiscoveryImmunology and Allergy
Research Topics (OpenAlex)
Monoclonal and Polyclonal Antibodies ResearchPharmaceutical studies and practicesAsthma and respiratory diseasesDrug-Induced Adverse ReactionsLegal Cases and CommentaryDiverse Scientific and Economic StudiesHuman auditory perception and evaluationDermatology and Skin DiseasesBiosimilars and Bioanalytical MethodsAtrial Fibrillation Management and Outcomes